- 1
- 0
- 约8.95千字
- 约 31页
- 2019-03-22 发布于福建
- 举报
IDSA guidelines: a central venous catheter (CVC) should be removed in patients with candidaemia whenever possible EFISG as well recommends: the removal of indwelling vascular access lines at least for patients receiving azoles or amphotericin B deoxycholate For patients receiving echinocandins this may not be as crucial as ‘‘removal of indwelling lines within 48 h after treatment initiation was not associated with a higher survival rate’’. a recent multivariate analysis of data from two phase III trials performed by Nucci et al. 45 did not find any benefit of early catheter removal. both tri
原创力文档

文档评论(0)